Literature DB >> 26398077

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Matias E Valsecchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26398077     DOI： 10.1056/NEJMc1509660

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  Breast Cancer Metastasis.

Authors:  Mi Young Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.

Authors:  Fang Zheng; Jianzhong Dang; Hongyu Zhang; Fangzhou Xu; Diandian Ba; Bingyu Zhang; Fanjun Cheng; Alfred E Chang; Max S Wicha; Qiao Li
Journal:  J Immunother       Date:  2018-10       Impact factor: 4.456

Review 3.  Recent advances in the clinical development of immune checkpoint blockade therapy.

Authors:  Atefeh Ghahremanloo; Arash Soltani; Seyed Mohamad Sadegh Modaresi; Seyed Isaac Hashemy
Journal:  Cell Oncol (Dordr)       Date:  2019-06-14       Impact factor: 6.730

Review 4.  Ipilimumab: from preclinical development to future clinical perspectives in melanoma.

Authors:  Paul Letendre; Varun Monga; Mohammed Milhem; Yousef Zakharia
Journal:  Future Oncol       Date:  2016-11-24       Impact factor: 3.404

Review 5.  Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Authors:  Steven S Yu; Tanya B Dorff; Leslie K Ballas; Sarmad Sadeghi; Eila C Skinner; David I Quinn
Journal:  Clin Adv Hematol Oncol       Date:  2017-06

Review 6.  Merkel Cell Carcinoma Therapeutic Update.

Authors:  Nicole M Cassler; Dean Merrill; Christopher K Bichakjian; Isaac Brownell
Journal:  Curr Treat Options Oncol       Date:  2016-07

7.  Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.

Authors:  Yan Qu; Shuqing Zhang; Yan Zhang; Xien Feng; Fengjuan Wang
Journal:  Virchows Arch       Date:  2020-11-12       Impact factor: 4.064

Review 8.  Immune checkpoint inhibitors: therapeutic advances in melanoma.

Authors:  Ivan Márquez-Rodas; Pablo Cerezuela; Ainara Soria; Alfonso Berrocal; Aldo Riso; María González-Cao; Salvador Martín-Algarra
Journal:  Ann Transl Med       Date:  2015-10

Review 9.  Current status and future perspectives of immunotherapy in bladder cancer treatment.

Authors:  Zhangsong Wu; Jinjian Liu; Ruixiang Dai; Song Wu
Journal:  Sci China Life Sci       Date:  2020-08-26       Impact factor: 6.038

10.  Efficacy of artificial liver support system in severe immune-associated hepatitis caused by camrelizumab: A case report and review of the literature.

Authors:  You-Wen Tan; Li Chen; Xing-Bei Zhou
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.